Crispr Therapeutics shares tumble after significant earnings miss
ALT5 Sigma Corporation (NASDAQ:ALTS), a $137.5 million market cap company whose stock has surged nearly 300% over the past year, announced changes to its board of directors this week, according to a press release statement and an SEC filing. InvestingPro data shows the company has demonstrated exceptional momentum, with shares up 77% year-to-date.
On Friday, the company’s president was informed of the passing of longtime director Richard Butler. Butler had served on the board since May 2015 and was chair of the Audit Committee as well as a member of the Compensation and Nominating and Corporate Governance Committees.
On Wednesday, David Danziger, 68, accepted an invitation to join the board of directors. Danziger recently retired as Senior Vice President, Assurance and National Leader of Public Companies at MNP LLP, a Canadian accounting firm, where he led audit teams and advised companies on public market transactions. He has more than four decades of experience in audit, compliance, and corporate governance, and has served on the boards of several public companies listed on exchanges including the TSX, Nasdaq, LSE, and TSXV. According to InvestingPro analysis, analysts maintain a Strong Buy rating on ALTS with a price target of $24.
Danziger will serve as chair of the Audit Committee and as a member of the Compensation and Nominating and Corporate Governance Committees. Upon his appointment, he was issued 10,000 shares of ALT5 Sigma common stock at $7.88 per share and will receive board fees of $1,200 per month. The company stated there were no arrangements or understandings with other persons in connection with his selection, and that Danziger has no family relationship with other directors or executive officers.
The information in this article is based on a press release statement and the company’s filing with the Securities and Exchange Commission.
In other recent news, ALT5 Sigma Corporation has been included in the Russell 3000E and Russell 3000E Growth Indexes as part of the 2025 Russell indexes reconstitution. This development follows the company’s previous inclusion in the Russell Microcap Index since June 2024. The inclusion is seen as a validation of the company’s growth and market presence. Additionally, ALT5 Sigma has integrated Lightning Network capabilities on its platform, facilitating instantaneous and low-cost Bitcoin transactions. This integration is expected to enhance transaction speed and efficiency for enterprises, with future plans to include Tether (USDT) stablecoin transactions. The company has also launched ALT5 Prime, a new product designed to provide financial institutions with a compliant way to enter the digital asset space. ALT5 Prime aims to reduce the time to market for institutions venturing into crypto trading platforms. Furthermore, ALT5 Sigma has joined the Securities Industry and Financial Markets Association (SIFMA), aligning itself with prominent U.S. broker-dealers and investment banks. These developments reflect ALT5 Sigma’s strategic direction in expanding its digital asset solutions and payment infrastructure.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.